RecruitingNot ApplicableNCT06338514

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsalgia Accompanied by Myofascial Pain Syndrome.


Sponsor

Kutahya Health Sciences University

Enrollment

50 participants

Start Date

Apr 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhomboid and trapezius trigger point.
  • Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher.
  • Ability to read and write

Exclusion Criteria7

  • History of spinal surgery.
  • Lesions, atrophy, or scars in the skin around the back.
  • Undergoing physiotherapy targeting the back and lumbar region in the last 6 months.
  • Undergoing an interventional procedure for back or lumbar pain in the last 3 months.
  • Use of steroids in the last 1 month.
  • Special conditions such as epilepsy, pregnancy, injection phobia, etc.
  • Inability to comply with the restriction on the use of steroid and non-steroidal anti-inflammatory drugs during the treatment period.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERReal dry needling

dry needling into the muscle under ultrasound guidance.

OTHERSham dry needling

dry needling into the subcutaneous fatty tissue under ultrasound guidance.


Locations(1)

Kütahya Health Sciences University

Kütahya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06338514


Related Trials